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Chlamydophila pneumoniae is an obligate intracellular respiratory pathogen that has been associated with 
pneumonia and chronic bronchitis, atherosclerosis, asthma and other chronic diseases in humans. 
However, C. pneumoniae is not restricted to humans, as originally thought, and can cause infections in 
several animal hosts. We isolated C. pneumoniae in cell culture from nine western barred bandicoots 
(Perameles bougainville) from Australia. The sequences of five genomic regions were determined 
including full-length sequences of the16S rRNA, ompA genes and YgeD-urk intergenic spacer and partial 
sequences of the 23S rRNA, and rpoB genes. Sequence analysis of the entire 16S rRNA and ompA genes 
from bandicoot isolates demonstrated that they were 98.2- 98.3% similar to human isolates, 94.6-99.3% 
to the equine biovar and almost identical with 99.5-99.9% similarity to the koala biovar. Comparative 
genotyping of the variable domain 4 region of the ompA gene demonstrated that bandicoot isolates 
seemed to be identical to the animal genotype that has been recently identified in human carotid plaque 
specimens. Minor sequence polymorphism observed in ompA, 16S rRNA and rpoB genes of animal 
isolates, indicating genomic diversity within C. pneumoniae, may have important implications for 
diagnostic PCR assays leading to false negative results. Forty percent of selected previously published 
species-specific PCR assays were found to have sequence variability in primer and/or probe that may 
affect their performance in detecting bandicoot isolates of C. pneumoniae, or possibly other animal and 
human strains where minor sequence polymorphisms may be present. The data of this study support the 
previous observations that C. pneumoniae is not restricted to humans and may be widespread in an animal 
reservoir with a potential risk of possible transmission to humans. 
 
INTRODUCTION 
 
Chlamydophila pneumoniae is an obligate intracellular bacterium responsible for respiratory infections 
(pneumonia and bronchitis) in adults and children, affecting up to 70% of the population worldwide at 
least once during his or her lifetime (Peeling & Brunham, 1996). Persistent C. pneumoniae infections 
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have been implicated in the development of atherosclerosis, asthma and other chronic diseases in humans 
(Balin et al., 1998; Blasi et al., 2002; Hanh et al., 1991; Wong et al., 1999).  
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C. pneumoniae was initially thought to be an exclusively human pathogen. However, several studies 
demonstrated that C. pneumoniae could also cause ocular, respiratory and urogenital infections in a wide 
variety of animal species, including koalas, horses, frogs and reptiles (Berger et al., 1999; Bodetti et al., 
2002; Hotzel et al., 2001; Jacobson et al., 2004; Storey et al., 1993). Current taxonomic classification 
divides C. pneumoniae into three distinct biovars: human biovar TWAR, biovar koala and biovar equine 
(Everett et al., 1999a). The distinction was based primarily on comparative sequence analysis of the 16S 
rRNA, 23S rRNA and ompA genes and biological characteristics. Human C. pneumoniae isolates were 
found to be almost identical to each other, with only 0.1 % difference in 16S rRNA gene and 0.4% 
difference in the ompA gene. While some of the animal isolates are almost identical to human strains, the 
others seem to be genetically more diverse, with up to 6% ompA gene dissimilarity (Bodetti et al., 2002). 
 
The existence of animal strains of C. pneumoniae raises the issue of possible transmission risk to humans. 
A recent study by Cochrane et al. (2005) where animal genotypes of C. pneumoniae were identified in 
human specimens and human genotypes were detected in koalas, supports the possibility of such 
transmission. However, no cases of zoonotic C. pneumoniae infections in humans have been described so 
far. 
 
In this study, C. pneumoniae was isolated from western barred bandicoots (Perameles bougainville) in 
cell culture and characterized by sequence comparison of five genomic regions relevant for molecular 
diagnostics, including 16S rRNA, 23S rRNA, ompA and rpoB genes and ygeD-urk intergenic spacer. The 
entire ompA and 16S rRNA genes, that are frequently used in species-specific PCR-based assays (Dowell 
et al., 2001; Loens et al., 2006) were sequenced and compared to the published sequences of human and 
animal C. pneumoniae isolates. Genotyping of the bandicoot isolates was performed in the variable 
domain 4 of the ompA gene, rpoB gene and ygeD-urk intergenic spacer loci. 
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METHODS 
 
Animals. All western barred bandicoots sampled in this study were from wild populations from Bernier 
island and Dryandra, Western Australia. Thirty-seven conjunctival, nasal, throat and cloacal swab 
specimens from twenty-one animals with clinical signs of ocular and/or respiratory disease were 
examined. 
 
Isolation and propagation of Chlamydiales. Isolation and propagation of Chlamydiales was performed 
by cell culture, as previously described (Roblin et al., 1992). Briefly, swab specimens were inoculated 
onto HEp-2 cell monolayers (ATCC CCL-23) by centrifugation at 1,700 x g for 1 hour. Infected 
monolayers were then overlaid with Iscove’s DMEM medium (Sigma-Aldrich, St. Luis, MO) 
supplemented with 10% fetal calf serum (Atlanta Biologicals, Lawrenceville, GA), 20mM L-glutamine 
and 1 µg/mL of cycloheximide and incubated at 35°C for 72 hours. Up to 6 passages were performed for 
each isolate. Following incubation, inoculated HEp-2 cells were fixed in ethanol and stained for specific 
chlamydial inclusions with Pathfinder Chlamydia Confirmation System (BioRad, Hercules, CA) for 30 
min at 37oC.  
 
DNA extraction. DNA from the cultured Chlamydiales was extracted using DNeasy Tissue kit (Qiagen, 
Valencia, CA) according to the manufacturer’s protocol. Human C. pneumoniae CWL029 (ATCC VR-
1310) and TW-183 (ATCC VR-2282) grown in HEp-2 cells were used as positive control in PCR assays. 
 
Chlamydiaceae specific PCR TaqMan assay.  The TQF and TQR primers and probe targeting the 
Chlamydiaceae specific region of 23S rRNA gene were as described by Everett et al. (1999b) (Table 1). 
PCR was performed using LightCycler 2.0 (Roche, Indianapolis, IN) system with DNA Master HybProbe 
kit (Roche, Indianapolis, IN), containing FastStart Taq DNA polymerase at the following conditions: 
initial denaturation step at 95oC for 10 min, then 45 cycles of denaturation at 95oC for 5 s, annealing at 
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60oC for 10 s, and extension at 72oC for 10 s. Products amplification was analyzed by manufacturers' 
supplied software.  
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C. pneumoniae specific PCR TaqMan assay. The primers QMOMP1, QMOMP2 and QMOMPS probe 
targeting an 85 bp C.pneumoniae specific region of the ompA gene are shown in Table 1. PCR was 
performed using the Roche system mentioned above, with predenaturation at 95oC for 10 min, then 45 
cycles of denaturation at 95oC for 5 s, annealing at 60oC for 10 s, and extension at 72oC for 10 s.  
 
16S and 23S rRNA genes signature sequencing. Amplification/sequencing primers used for 16S rRNA 
gene and 23S rRNA gene products were 16SIGF, 16SIGR, U23F and 23SIGR (Table 1). PCR was 
performed using Qiagen ProofStart DNA polymerase kit (Qiagen, Valencia, CA), with initial denaturation 
at 95oC for 5 min, then 45 cycles of denaturation at 94oC for 30 s, annealing at 60oC for 30 s, extension at 
72oC for 60 s, with a final extension for 5 min at 72oC. Following amplification, the products were 
separated by electrophoresis in 2% agarose E-gel (Invitrogen, Carlsbad, CA) and visualized by using 
ultraviolet transilluminator. PCR products were purified with QIAquick PCR Purification kit (Qiagen, 
Valencia, CA) and sequenced in both directions (GeneWiz, North Brunswick, NJ). 
 
OmpA gene sequencing. DNA fragment containing the entire ompA gene was amplified with CpompA1F 
and CpompA3R primers (Table 1). PCR was performed using ProofStart DNA polymerase kit, with 
initial denaturation step at 95oC for 5 min, then 40 cycles of denaturation at 94oC for 30 s, annealing at 
55oC for 30 s, extension at 72oC for 60 s, with a final extension for 5 min at 72oC. Following 
electrophoresis in 2% agarose E-gel. PCR products were visualized by using ultraviolet transilluminator. 
PCR products containing 1170 bp ompA gene were sequenced in both directions, with overlap, using the 
sequencing primers shown in Table 1. These primers were designed using Primer3 software 
[http://frodo.wi.mit.edu/cgi-bin/ primer3/primer3_www.cgi] (Rozen & Skaletsky, 2000). 
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16S rRNA gene sequencing. DNA region containing the entire 16S rRNA gene was amplified with 
Cp16SF and Cp16SRb primers (Table 1). PCR was performed using ProofStart DNA polymerase kit, 
with initial denaturation step at 95
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oC for 5 min, then 45 cycles of denaturation at 94oC for 30 s, annealing 
at 55oC for 30 s, extension at 72oC for 60 s, with a final extension for 5 min at 72oC. Following 
electrophoresis in 2% agarose E-gel, PCR products were visualized and purified with QIAquick PCR 
Purification kit. PCR products containing 1552 bp 16S rRNA gene were sequenced in both directions, 
with overlap, using the following primers: Cp16SF1, Cp16SR1, Cp16SF2, Cp16SR2, Cp16SF3, 
Cp16SR3, Cp16SF4 and Cp16SR4 (Table 1). The above primers were designed using Primer3 program. 
 
RpoB gene sequencing. A 733 bp section of the DNA-directed RNA polymerase beta gene (rpoB) 
containing segment matching PstI fragment (Campbell et al., 1992) was amplified using CprpoBFc and 
CprpoBRc primers (Table 1), designed using Primer3.  PCR was performed using ProofStart DNA 
polymerase kit, with initial step at 95oC for 5 min, then 45 cycles of denaturation at 94oC for 30 s, 
annealing at 55oC for 30 s, extension at 72oC for 60 s, with a final extension for 5 min at 72oC. PCR 
products were purified and sequenced in both directions using the same primer pair. 
 
YgeD-urk intergenic spacer sequencing.  A 621 bp fragment spanning YgeD-urk intergenic spacer was 
amplified and sequenced using OUT1 and OUT2 primers (Table 1). PCR was performed using ProofStart 
DNA polymerase kit at the above conditions. Prior to sequencing products were purified from 2% agarose 
E-gels with QIAquick PCR Purification kit. 
 
Sequence analysis.  The sequences were analyzed using BLAST 2 [http://www.ncbi.nlm.nih.gov/blast/ 
bl2seq/ bl2.html] (Tatusova & Madden, 1999) and compared to the Chlamydiales sequences of 16S rRNA, 
23S rRNA, rpoB and ompA genes available in GenBank, including three biovars of C. pneumoniae. C. 
pneumoniae isolates which sequences were used for comparative analysis, are shown in Table 2. 
ClustalW multiple sequence alignment was performed using MegAlign 5.0 program (DNAStar, Madison, 
WI). The sequences of the entire ompA and 16S rRNA genes, partial sequences of 23S rRNA and rpoB 
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genes and YgeD-urk intergenic spacer from bandicoot C. pneumoniae were submitted to GenBank; 
accession numbers DQ358972, DQ444323, DQ465990, DQ460031 and DQ463439, respectively.  
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RESULTS AND DISCUSSION 
 
This is the first report of C. pneumoniae isolated and characterized in a third affected mammalian species. 
This species, western barred bandicoots are small endangered marsupials whose natural habitat is 
currently limited to Bernier and Dorre islands of the West Coast of Australia. However, uncultured 
unspeciated Chlamydiales and C. pecorum have been previously detected in these animals by molecular 
based methods (Bodetti et al., 2003; Warren et al., 2005). 
 
Isolation and speciation. Ten swab specimens (6 ocular, 3 throat and 1 nasal) from nine western barred 
bandicoots were positive by isolation in cell culture followed by staining with family specific monoclonal 
antibody against chlamydial lipopolysaccharide. These isolates were propagated by cell culture to 103-104 
inclusion forming units (IFU)/ml and were confirmed as Chlamydiaceae by 23S rRNA gene-based PCR. 
Sequence analysis of the 16S and 23S rRNA signature sequences described by Everett et al. (1999a) 
revealed that all 10 bandicoot isolates belonged to the C. pneumoniae species and were more than 99.1% 
similar to C. pneumoniae isolates of human and animal origin, with only 1-5 bp variations. 
 
OmpA gene based PCR and sequencing. All ten bandicoot isolates were tested positive by C. 
pneumoniae specific ompA-based PCR as per originally described protocol (Apfalter et al., 2003) that 
confirmed them as C. pneumoniae. However, fluorescence signal was approximately 1.7 times lower than 
in human C. pneumoniae control as shown in Figure 1. Increase in annealing temperature resulted in 
negative fluorescence signal for all bandicoot isolates but did not affect the signal for human C. 
pneumoniae control (data not shown).  Possible sequence variation between bandicoot and human isolates 
in the area where published primers and probe meant to bind the target sequence was suspected.  
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To address this performance problem of the ompA based PCR, the entire ompA gene was amplified and 
sequenced for all isolates.  OmpA genes of all bandicoot C. pneumoniae isolates were identical to each 
other. As seen in Figure 2, nucleotide alignment of the 85 bp target region used in ompA based TaqMan 
assay did reveal one single nucleotide polymorphism (SNP) in the forward primer and two SNPs in the 
probe sequence as compared to human isolates of C. pneumoniae. Overall, the entire ompA gene sequence 
from bandicoot C. pneumoniae was found to be 98.2% and 94.6% similar to human and equine biovars, 
respectively (Table 3); and almost identical, 99.9% similarity, to koala biovar (1 bp difference). This SNP 
at position 982 resulted in amino acid substitution from alanine in koala biovar to proline in bandicoot C. 
pneumoniae. 
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16S rRNA gene sequencing. 16S rRNA gene, which is also frequently used as a target for identification 
and speciation of Chlamydiales and other bacteria, was also amplified and sequenced for all bandicoot 
isolates. All bandicoot isolates were identical to each other and very similar to human and animal C. 
pneumoniae isolates as shown in Table 3. Minor nucleotide differences in both 16S rRNA and ompA 
genes may indicate genomic diversity within animal C. pneumoniae strains, as previously suggested 
(Hotzel et al., 2001).  
 
The identification of C. pneumoniae infection in western barred bandicoots further proves that this 
species is not restricted to humans, and may exist in an animal reservoir with a possible transmission risk 
to humans. Coles et al. (2001) demonstrated that animal strains of koala biovar are able to infect and 
multiply in human respiratory cells and monocytes. Recently, Cochrane et al. (2005) identified an animal 
genotype of C. pneumoniae in carotid arteries and PBMC specimens from humans, and human genotype 
in PBMC specimens from koalas by using nested ompA- and ygeD-urk-based PCR and sequencing 
assays. The authors suggested that C. pneumoniae might be capable of being transmitted between human 
and animals. 
 
Genotyping.  Data on genotyping of human and animal strains of C. pneumoniae are limited. 
 9 
For genotyping purposes three genomic targets were selected: variable domain 4 region (VD4) of the 
ompA gene, YgeD-urk intergenic spacer and a region of the rpoB gene matching PstI fragment.   
215 
216 
217 
218 
219 
220 
221 
222 
223 
224 
225 
226 
227 
228 
229 
230 
231 
232 
233 
234 
235 
236 
237 
238 
239 
240 
241 
 
VD4 genotyping. VD4 was proposed as a possible genotyping target due to its small size and high degree 
of variability between human and animal isolates (Cochrane et al., 2005; Wardrop et al., 1999). Bodetti et 
al. (2002) suggested a genotyping system based on as little as 1 bp sequence polymorphism in VD4 
segment of ompA gene. We analyzed C. pneumoniae VD4 sequences publicly available in the GenBank 
database and identified 22 sequences that we separated into 3 human and 7 animal genotype groups 
(based on their sequence identity within a group) as presented in Table 4. Sequence alignment of the 174 
bp region of the VD4 segment demonstrated that bandicoot isolates differed from human isolates by 6-7 
SNPs and were identical to previously reported koala and frog isolates (genotype group A5) and, 
according to the Cochrane et al. (2005) designations, would be assigned to genotype D.  Interestingly, the 
animal C. pneumoniae isolates from genotype group A1 from reptiles and amphibians (Bodetti et al., 
2002) were absolutely identical to human isolates from group H1 as shown in Figure 3. 
 
YgeD-urk genotyping. The intergenic spacer region between YgeD and urk genes differs by the 
orientation of a 23 bp segment in one of the human C. pneumoniae strains (Read et al., 2000) and was 
used for genotyping of C. pneumoniae, (Cochrane et al., 2005). The results of the 320 bp YgeD-urk spacer 
genotyping are shown in Figure 4. The bandicoot isolates were identical to CpnIII genotype recently 
found in humans (Cochrane et al., 2005) and had the 23 bp invertible region in the same orientation as 
human TW-183, AR39 and J138 strains. There was a 3 bp difference as compared to human isolates. 
 
RpoB genotyping. RpoB gene was of relevant interest because of its current use as a target in C. 
pneumoniae specific PCR assays (Dowell et al., 2001; Loens et al., 2006). Sequence analysis of the rpoB 
gene region that matched the PstI fragment (Campbell et al., 1992) showed a 1 bp polymorphism as 
compared to human strains of C. pneumoniae (Figure 5). This nucleotide change at position 2946 was a 
silent mutation with no amino acid change (alanine). 
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C. pneumoniae species-specific PCR assays and sequence polymorphism. The results of this study 
may have important implications for molecular diagnostics of C. pneumoniae infection in both animals 
and humans. Since most of the C. pneumoniae specific PCR assays were developed and evaluated using 
human isolates, they may not be appropriate for detection of animal strains. Even minor sequence 
variability in the target regions can significantly compromise the sensitivity of the PCR assay and result 
in false negative results due either to target amplification failure (primer sequence polymorphism) or 
target detection failure (probe sequence polymorphism) (Kwok et al., 1990; Stevenson et al., 2005). As 
we demonstrated in this study a real-time ompA based PCR assay developed for human strains either 
generated a lower fluorescent signal or failed to detect bandicoot C. pneumoniae isolates because there 
was one SNP in the forward primer and two SNPs in the probe. Similar assay performance problems due 
to target sequence variability have been recently reported for real-time PCRs for detection of herpes 
simplex virus and Listeria monocytogenes (Rodriguez-Lazaro et al., 2004; Stevenson et al., 2005). We 
analyzed several published and currently used C. pneumoniae species-specific PCR assays for the 
presence of the sequence polymorphism in the target regions as shown in Table 5.  We found that 6 out of 
15 species-specific PCR assays had sequence variability in primer and/or probe that may affect their 
performance in detecting bandicoot strain of C. pneumoniae, or possibly other animal and human strains 
where minor sequence polymorphism may be present. 
 
The expanding number of animal hosts and isolates of C. pneumoniae and genetic similarity of animal 
and human strains raises some interesting questions about the evolution and epidemiology of this 
pathogen. It is quite possible that C. pneumoniae was primarily an animal pathogen, which was only 
recently, in evolutionary terms, acquired by humans. Considering almost universal exposure of humans to 
C. pneumoniae and generally inefficient mode of transmission from person to person (Blasi et al., 1998), 
one could hypothesize that an environmental source of C. pneumoniae should be in close proximity to 
humans. While possible zoonotic transmission of C. pneumoniae from exotic animals occupying a unique 
environmental niche (koalas and bandicoots) to humans seems unlikely, acquisition by contact with 
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animals living in urban or rural areas, including domestic and production animals, either directly or via a 
transmission vector such as free-living protozoa could be possible (Essig et al., 1997). However, in 
addition to the previously described equine biovar (Storey et al., 1993) there have been only two reports 
of possible C. pneumoniae infection in domesticated animals.  Sako et al. (2002) described detection of 
C. pneumoniae antigens in vascular specimens from dogs and Canderle et al. (2005) reported high 
prevalence of C. pneumoniae species-specific antibodies in boars. 
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More targeted research efforts are necessary to determine the prevalence and host range of C. pneumoniae 
in environmental reservoirs of different geographic regions since most of the published reports on animal 
strains were simply serendipitous findings. There is also a need for development of relevant and 
consistent genotyping system to be used for epidemiological surveillance, pathogenesis, evolution studies 
and characterization of novel C. pneumoniae isolates. 
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Table 1. Oligonucleotides used in this study. 420 
421  
 
Name 
 
Target gene 
 
 
Sequence 
 
Primer location  
(C. pneumoniae TW-183 
genome numbering) 
 
 
Application 
 
Product 
size (bp) 
 
Reference 
 
QMOMP1 
 
ompA 
 
5’-GATCCGCTGCTGCAAACTATACT-3’ 
 
176626-176648 
 
Real time PCR 
 
85  
 
Apfalter et al., 2003 
QMOMP2  5’-GTGAACCACTCTGCATCGTGTAA-3’ 176688-176710 Real time PCR   
probe   5’- FAM-TAGGCCGGGTTAGGTCTATCTACGGCAGT -TAMRA-3’ 
 
176649-176677 
 
Real time PCR 
 
  
    
    
    
   
       
   
       
       
   
     
    
    
    
     
      
     
       
       
       
       
       
       
   
 
 
  
    
     
   
    
   
    
CpompA1F ompA 
 
5'-TCGTGTCGCCAAAATATGAG-3' 176283-176302 PCR/sequencing 1344
 
 This study
 CpompA3R
 
5'-GGGGGAATAAAAATTGCTCA-3'
 
177607-177626
 
PCR/sequencing
 
CpompA1R ompA
 
5'-CCAACGAGATTGAACGCTGT-3'
 
176802-176821 Sequencing -
 
This study
 CpompA2F 5'-GCAGGCTTCATTGCCTTAAA-3' 176715-176734 Sequencing
CpompA2R 5'-GCGGATGTTATCAGCATCAA-3' 177235-177254 Sequencing
CpompA3F
 
5'-GGAACAAAGTCTGCGACCAT-3'
 
177123-177142
 
Sequencing
 
16SIGF 16S rRNA
 
5’-CGGCGTGGATGAGGCAT-3’ 96733-96749 PCR/sequencing 294
 
Everett et al.,1999a 
 16SIGR 5’-TCAGTCCCAGTGTTGGC-3’
 
97010-97026
 
PCR/sequencing
 
Cp16SF 16S rRNA 
 
5’-GATGTGGATACGCAACGAAA-3’ 96550-96569 PCR 1796  
 
This study 
 Cp16SRb 5’-TGAAAACAACCTTAACAATGCAA-3’
 
98323-98345
 
PCR
Cp16SF1 16S rRNA
 
5’-TGCAGGCCAGTATAAAATGC-3’ 96634-96653 Sequencing - This study
 Cp16SR1 5’-TAAGGCCTTCATCACACACG-3’ 97104-97123 Sequencing
Cp16SF2 5’-ACACTGCCCAGACTCCTACG-3’ 97028-97047 Sequencing
Cp16SR2 5’-CATCGTTTACGGCAAGGACT-3’ 97503-97522 Sequencing
Cp16SF3 5’-GAAAGCAAGGGGAGCAAAC-3’ 97466-97484 Sequencing
Cp16SR3 5’-CCATTGTAGCACGTGTGTCG-3’ 97924-97943 Sequencing
Cp16SF4 5’-ATGACGTCAAGTCAGCATGG-3’ 97889-97908 Sequencing
Cp16SR4 5’-CCCAACCTAGTCGGGTTGTT-3’
 
98272-98291 Sequencing
   
TQF 23S rRNA
 
5′-GAAAAGAACCCTTGTTAAGGGAG-3′ 98986-99008 Real time PCR 128  Everett et al., 1999b 
TQR 5′-CTTAACTCCCTGGCTCATCATG-3′ 99092-99113 Real time PCR   
probe 5′-FAM-CAAAAGGCACGCCGTCAAC-TAMRA-3’ 
 
99073-99091 
 
Real time PCR 
 
  
U23F 23S rRNA
 
5’-GATGCCTTGGCATTGATAGGCGATGAAGGA-3’
 
98502- 98531 PCR/sequencing 602
 
Everett et al.,1999a 
 23SIGR 5’-TGGCTCATCATGCAAAAGGCA-3’
 
99083- 99103
 
PCR/sequencing
 
CprpoBFc rpoB 5’-CGAACTTGTAGAAGAAGCTGTTCA-3’ 94409-94432 PCR/sequencing 733  This study 
CprpoBRc 
 
 5’- AAAGCGTTCACCTGTCTTCC -3’ 
 
95122- 95141 
 
PCR/sequencing 
 
  
OUT1 YgeD-urk spacer 
 
5'-GTTAGGGTGGTTTTCCCAGC-3' 221724-221743 PCR/sequencing 621  
 
Cochrane et al., 2005 
 OUT2 5'-GAGATAACGATTCTGAGGCC-3' 222325-222344 PCR/sequencing
 
 422 
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Table 2. C. pneumoniae sequences used for comparative analysis.  423 
 
Chlamydophila pneumoniae 
(host, isolates)     
 
 
Gene 
 
GenBank 
accession no. 
 
Reference 
 
Human, TW-183 
 
 
 
 
 
Human, AR39  
 
 
 
 
 
Human, CWL029  
 
 
 
 
 
Human, J138  
 
 
 
 
 
Human, MS isolate  
 
Human, IOL 207  
 
 
Human, LKK-1 
 
Human, CpnB 
 
Human, CpnC 
 
Human, CpnIII 
 
ompA 
16S rRNA 
23S rRNA 
rpoB 
ygeD-urk intergenic spacer 
 
ompA 
16S rRNA 
23S rRNA 
rpoB 
ygeD-urk intergenic spacer 
 
ompA 
16S rRNA 
23S rRNA 
rpoB 
ygeD-urk intergenic spacer 
 
ompA 
16S rRNA 
23S rRNA 
rpoB 
ygeD-urk intergenic spacer 
 
ompA 
 
ompA 
16S rRNA 
 
ompA 
 
ompA 
 
ompA 
 
ygeD-urk intergenic spacer 
 
AE017159  
AE017160 
AE017160 
AE017157 
AE017159 
 
AE002161  
AE002161 
AE002161 
AE002161 
AE002161 
 
AE001363  
AE001363 
AE001363 
AE001363 
AE001363 
 
BA000008  
BA000008 
BA000008 
BA000008 
BA000008 
 
AF131889  
 
M64064  
Z49874 
 
AY555078 
 
AY426606 
 
AY426607 
 
AY427827 
 
- 
- 
- 
- 
- 
 
Read et al., 2003  
Read et al., 2003 
Read et al., 2003 
Read et al., 2003 
Read et al., 2003 
 
Kalman et al., 1999   
Kalman et al., 1999 
Kalman et al., 1999 
Kalman et al., 1999 
Kalman et al., 1999 
 
Shirai et al., 2000  
Shirai et al., 2000 
Shirai et al., 2000 
Shirai et al., 2000 
Shirai et al., 2000 
 
Sriram et al., 1998  
 
Carter et al., 1991 
Wilson et al., 1996 
 
- 
 
Cochrane et al., 2005 
 
Cochrane et al., 2005 
 
Cochrane et al., 2005 
 
Western barred bandicoots, WBB 
 
 
 
 
 
African clawed frog, CPXT1 
 
 
African frog, DE177 
 
 
Blue Mountains tree frog, tree frog type I 
 
Giant barred frog, frog Mi-1 
 
Burmese python, burmese python type I 
 
Iguana, iguana type I 
 
 
Puff adder, puff adder type I 
 
Green sea turtle, turtle type I  
 
Chameleon, chameleon type I       
 
Koala, koala  type I 
 
Koala, LPConU 
 
 
Koala, koala 
 
Horse, N16 
 
ompA 
16S rRNA 
23S rRNA 
rpoB 
ygeD-urk intergenic spacer 
 
ompA 
16S rRNA 
 
ompA 
16S rRNA 
 
ompA 
 
ompA 
 
ompA 
 
ompA 
16S rRNA 
 
ompA 
 
ompA 
 
ompA 
 
ompA 
 
ompA 
16S rRNA 
 
ompA 
 
ompA 
16S rRNA 
23S rRNA 
 
DQ358972 
DQ444323 
DQ465990 
DQ460031 
DQ463439 
 
AF184214 
AF139200 
 
AF347608 
AF347610 
 
AY026516 
 
AF102830 
 
AY026517 
 
AY026518  
AF451290 
 
AY026519  
 
AY026520  
 
AY026515 
 
M73038 
 
AF100958 
AF100957 
 
X72023 
 
L04982 
U68426 
U68426 
 
This study 
This study 
This study 
This study 
This study 
 
Reed et al., 2000 
Reed et al., 2000 
 
Hotzel et al., 2001 
Hotzel et al., 2001 
 
Bodetti et al., 2002 
 
Berger et al., 1999 
 
Bodetti et al., 2002 
 
Bodetti et al., 2002 
Bodetti et al., 2002 
 
Bodetti et al., 2002 
 
Bodetti et al., 2002 
 
Bodetti et al., 2002 
 
Kaltenboeck et al., 1993 
 
Wardrop et al., 1999 
Wardrop et al., 1999 
 
Girjes et al., 1994 
 
Storey et al., 1993 
Everett et al., 1999a 
Everett et al., 1999a 
 424 
425 
426 
427 
428 
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Table 3. Sequence similarities in five genomic regions of western barred bandicoot isolates compared to existing C. pneumoniae biovars/isolates (%). 429 
430  
 
Chlamydophila pneumoniae 
biovars 
 
 
ompA gene 
(1170 bp) 
 
16S rRNA gene 
(1552 bp) 
 
 
23S rRNA segment 
(551 bp) 
 
rpoB segment 
(687 bp) 
 
ygeD-urk intergenic 
spacer (320 bp) 
 
 
Human biovar 
     TW-183,  
     AR39 
     J138  
     CWL029   
     IOL-207  
 
 
98.2 
98.2 
98.2 
98.2 
98.2 
 
 
99.6 
99.6 
99.4 
99.5 
99.6 
 
 
99.6 
99.6 
99.6 
99.6 
na*
 
 
99.9 
99.9 
99.9 
99.9 
na 
 
 
99.1 
99.1 
99.1 
95.9 
na 
 
Koala biovar  
     Koala type I, LpConU 
 
 
99.9 
 
 
99.5 
 
 
na 
 
 
na 
 
 
na 
      
Equine biovar 
     N16 
 
 
94.6 
 
 
99.3 
 
 
99.1 
 
 
na 
 
 
na 
 
Other isolates 
     African clawed frog  
 
 
na 
 
 
99.7 
 
 
na 
 
 
na 
 
 
na 
 
Other Chlamydophila species 
 
 
<74.6 
 
<96.3 
 
<94.7 
 
<84.0 
 
-§
 431 
432 
433 
* - not available 
§ – no significant similarity found by BLASTn search 
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WBB 37 Human TW-183 Negative control
434 
435 
436 
437 
438 
 
 
Fig. 1. Fluorescence signal of species-specific ompA-based real time PCR of bandicoot C. 
pneumoniae isolates (WBB).   
 21 
 439 
440 
441 
272                                                                                                                                                                                               356 
........A...................G.................T...................................... WBB GATCCGCTGCTGCAAACTATACTACTGCCGTAGATAGACCTAACCCGGCCTACAATAAGCATTTACACGATGCAGAGTGGTTCAC Human  442 
443 
444 
445 
446 
447 
448 
449 
450 
Primer QMOMP1                   Probe QMOMPS                            Primer QMOMP2      
 
 
 
  
 
Fig. 2. Nucleotide sequence alignment of the 85 bp ompA target region, used in C. pneumoniae specific TaqMan PCR assay. Dots indicate 
the same nucleotides as in sequences of human isolates (TW-183, CWL029, AR-39 and J138). 
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Table 4. C. pneumoniae genotype groups based on the bp difference at the VD4 locus of the ompA gene. 451 
452  
 
Origin 
 
 
Genotype group 
 
C. pneumoniae isolates  
 
Human 
 
H1 
 
 
H2 
 
H3 
 
TW-183, AR39, CWL029, J138, MS isolate, IOL 207, 
LKK-1 
 
CpnB  
 
CpnB 
 
 
Animal 
 
A1 
 
 
A2 
 
A3 
 
A4 
 
A5 
 
A6 
 
A7 
 
 
burmese python type I, iguana type I, puff adder type I, 
turtle type I, tree frog type I 
 
chameleon type I 
 
DE177 
 
CPXT1 
 
koala type I, LPConU, frog Mi-1, WBB isolates 
 
koala 
 
N16 
453 
 23 
826                                                                                 912  453 
454 
455 
456 
457 
458 
459 
460 
461 
462 
463 
464 
465 
466 
467 
468 
469 
470 
471 
472 
473 
474 
475 
476 
477 
478 
479 
480 
481 
482 
..T.................................................................................... WBB* 
TACAGACTAAACTCTTTAGTGCCATACATTGGAGTACAATGGTCTCGAGCAACTTTTGATGCTGATAACATCCGCATTGCTCAGCCA Group H1  
....................................................................................... Group H2 
....................................................................................... Group H3 
....................................................................................... Group A1 
....................................................................................... Group A2 
....................................................................................... Group A3 
.....G................................................................................. Group A4 
..T.................................................................................... Group A5 
..T.................................................................................... Group A6 
..T.....C..........................C................................................... Group A7 
 
913                                                                                 999 
.........................................................A.G...A.....C......G.......... WBB 
AAACTACCTACAGCTGTTTTAAACTTAACTGCATGGAACCCTTCTTTACTAGGAAATGCCACAGCATTGTCTACTACTGATTCGTTC Group H1 
..........................................C............................................ Group H2 
..............................................................G........................ Group H3 
....................................................................................... Group A1 
.............T......................................................................... Group A2 
...............................................................A.....C......A.......... Group A3 
...............................................................A............A.......... Group A4 
.........................................................A.G...A.....C......G.......... Group A5 
.........................................................A.G...A.....G......G.......... Group A6 
..G............A.....................................G.G.........TG.T...T.AT.....CAA... Group A7 
 
 
Fig. 3. Nucleotide sequence alignment of a 174 bp region within VD4 segment of bandicoot C. pneumoniae ompA gene with human and 
animal genotype. Dots indicate the same nucleotide as in sequences of human H1 group. GenBank accession number for WBB isolates is 
DQ358972. 
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1                                                                                       90 
483 
484 
485 
486 
487 
488 
489 
490 
491 
492 
493 
494 
495 
496 
497 
498 
499 
500 
501 
502 
503 
504 
505 
506 
507 
508 
509 
510 
511 
512 
513 
514 
515 
516 
517 
518 
519 
520 
.....................................A...........................G........................ WBB 
GGAGTCTTGTACTCCTTTAGGAAACATCTAAGATACCGTAAATCGTTCTTATAAGGCATTCTGACAGTGTTTTTGCTTTTTTAAATCTAT AR39, TW-183, J138 
.......................................................................................... CWL029 
.....................................A...........................G........................ CpnIII 
 
91                                                                                     180 
.................................................................................G........ WBB 
CTATACGTGAATTGGGGTTTTGTATAACATCCCTTGTTTATTGGGGGATGAAATATTTTTTTGGATAGAATTCTATCCTAAACTTCGTGA AR39, TW-183, J138 
.......................................................................................... CWL029 
.................................................................................G........ CpnIII 
 
181                                                                                    269 
..........................-............................................................... WBB  
TCAGAAAATGACTATATCTAAAGATT-TCAATTTCTGATCACGAAGCTTTTTCTTTTGTCTCCTTTTAAATCAATAAATTCTCAAAGGAC AR39, TW-183, J138 
.......T...A-..C.T..G.T..AG...T........................................................... CWL029 
..........................-............................................................... CpnIII 
 
270                                             320 
...................................................                                        WBB 
CCGCATTTTGTTGTGTGCTGATTACAAGAGAAGTACTAAGGAGAAAAATTT                                        AR39, TW-183, J138  
...................................................                                        CWL029 
..................                                                                         CpnIII 
 
Fig. 4. Nucleotide sequence alignment of a 320 bp YgeD-urk intergenic spacer of bandicoot and human isolates. Dots indicate the same 
nucleotide as in sequences of human AR39, TW-183 and J138 isolates and dashes represent gaps in the sequences. CpnIII is a                   
C. pneumoniae genotype identified in human carotid specimens, GenBank accession number AY427827 (11)   
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 521 
522 
523 
524 
2783                                                                        2862 
................................................................................ WBB 
CCATTATTCACCGTCGTACAGCAGAAATCGTTGTTCATGAAGGCCTACTCTTTGATCAAGAGACAATAGAACGGATAGAA Human* 
................................................................................ PstI 525 
526 
527 
528 
529 
530 
531 
532 
533 
534 
535 
536 
537 
538 
539 
540 
541 
542 
543 
544 
545 
546 
547 
548 
549 
                             HL-1   
2863                                                                        2942 
................................................................................ WBB 
CAAGAAGATTTAGTGGATCTTTTAATGCCTAACTGTGAAATGTATGAAGTGTTGAAAGGACTTCTATCAGATTACGAAAC Human 
................................................................................ PstI 
 
2943                                                                        3022 
...C............................................................................ WBB 
GGCATTACAACGGCTAGAAATCAATTATAAGACTGAAGTTGAGCATATTCGTGAGGGAGATGCAGATTTAGATCATGGTG Human 
................................................................................ PstI 
 
3023                                                                        3101 
............-................................................................... WBB 
TCATTCGCCAAG-TTAAAGTCTACGTTGCCTCTAAGAGAAAACTTCAAGTTGGAGATAAAATGGCTGGACGACACGGAAA Human 
............G................................................................... PstI  
 
3102                                                                        3180 
.............................................................................-.. WBB 
TAAAGGTGTTGTTTCCAAAATCGTTCCCGAAGCGGATATGCCATATCTCTCTAACGGAGAAACTGTACAAATGATCC-TG Human 
.............................................................................C.. PstI  
 
3181                                                                  3253 
.......................................................-..................       WBB 
AACCCCCTCGGGGTGCCTTCAAGGATGAACCTTGGACAGGTATTAGAAACACACC-TAGGTTATGCAGCAAAAA       Human 
.......C.TC............................................G.................C       PstI  550 
551 
552 
553 
554 
555 
556 
557 
                                                               HR-1 
 
Fig. 5. Nucleotide sequence alignment of a 474 bp region of rpoB gene (matching PstI fragment) of human and WBB isolates. Dots 
indicate the same nucleotides as in human isolates and dashes represent gaps in the sequence. Human isolates represented by TW-183, 
CWL029, AR39 and J138. Primer sequences HL-1 and HR-1 used C. pneumoniae specific PCR assay (8) are shown in bold/underlined. 
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Table 5. Sequence variability in the target regions of the selected species-specific PCR assays as compared to 
bandicoot C. pneumoniae isolates. 
558 
559 
 
Sequence polymorphism (bp) 
 
 
PCR type 
 
Gene, product 
size (bp) 
 
Forward primer 
(outer/inner) 
 
 
Reverse primer 
(outer/inner) 
 
Probe 
 
Target 
total 
 
Reference 
 
Real-time 
 
ompA, 185 
 
1 
 
0 
 
2 
 
3 
 
Apfalter et al., 2003 
 
Real-time 
 
ompA, 134 
 
0 
 
0 
 
0 
 
1 
 
Meijer et al., 1998 
 
Real-time 
 
ompA, 79 
 
0 
 
0 
 
0 
 
0 
 
Kuoppa et al., 2002 
 
Real-time 
 
Real-time 
 
ompA, 109 
 
ompA, 126 
 
0 
 
0 
 
0 
 
0 
 
2 
 
0 
 
5 
 
5 
 
Tondella et al., 2002 
 
Tondella et al., 2002 
 
Real-time 
 
ompA, 72 
 
0 
 
0 
 
0 
 
0 
 
Kohlhepp et al., 2005 
 
Nested* 
 
ompA, 333 
 
0/0 
 
0/1 
 
- 
 
4 
 
Tong & Sillis, 1993 
 
Nested 
 
ompA, 497 
 
1/1 
 
0/1 
 
- 
 
13 
 
Lindholt et al., 1998 
 
Single-step* 
 
rpoB, 438 
 
0 
 
1 
 
- 
 
3 
   
Campbell et al., 1992 
 
Real-time 
 
rpoB, 82 
 
0 
 
0 
 
0 
 
0 
 
Welti et al., 2003 
 
Real-time 
 
16S rRNA, 149 
 
0 
 
0 
 
0 
 
2 
 
Meijer et al., 1998 
 
Single-step* 
 
16S rRNA, 195 
 
0 
 
0 
 
- 
 
0 
 
Madico et al., 2000 
 
Real-time 
 
16S rRNA, 195 
 
0 
 
0 
 
0 
 
2 
 
Hardick et al., 2004 
 
Single-step* 
 
16S rRNA, 464 
 
0 
 
0 
 
- 
 
2 
 
Gaydos et al., 1992 
 
Real-time 
 
16S rRNA, 154 
 
1 
 
0 
 
0 
 
2 
 
Templeton et al., 2005 
 
 560 
561 * These assays meet CDC validation criteria (Dowell et al., 2001).  
